SPECTRUM PHARMACEUTICALS INC Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Spectrum Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2022.
  • Spectrum Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2023 was -$5.01M, a 67.6% increase year-over-year.
  • Spectrum Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2023 was -$65M, a 53.1% increase year-over-year.
  • Spectrum Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$75.4M, a 52.5% increase from 2021.
  • Spectrum Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$159M, a 1.39% increase from 2020.
  • Spectrum Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2020 was -$161M, a 42.8% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$75.4M +$83.2M +52.5% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 -$159M +$2.24M +1.39% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$161M -$48.2M -42.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-18
2019 -$113M +$8.05M +6.67% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$121M -$28.6M -31% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-02
2017 -$92.2M -$22.4M -32.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 -$69.8M -$17.1M -32.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$52.6M -$6.92M -15.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 -$45.7M +$16.4M +26.4% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-14
2013 -$62.1M -$156M -166% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 $94.2M +$44.3M +88.7% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-13
2011 $49.9M +$98.8M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-12
2010 -$48.8M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.